Early Access — free while we kick the tires
EdgarHawk

Marshall Tyson Eliot

GENERAL COUNSEL & CORP. SEC.

Officer
2 filings analyzed · 1 company · Latest 2025-11-21

Never miss a filing from Marshall Tyson Eliot

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Alphatec Holdings, Inc. ATEC 0 2 Net selling

Activity

November 2025
high
Sell
70,000 shares
$1,365,700
Significance 6/10

General Counsel Marshall Tyson Eliot sold 70,000 shares of ATEC at $19.51 on 2025-11-20, reducing holdings by 16.0% to 368,331 shares.

Marshall Tyson Eliot, General Counsel & Corporate Secretary, executed a substantial open-market sale of 70,000 shares ($1.4M) on 2025-11-20, reducing his position by 16.0% from 438,331 shares to 368,331 shares. The sale occurred at $19.51, slightly below the current price of $20.31 and near the 52-week high of $20.75, during a period of strong momentum (+29.6% over 30 days, +25.9% over 90 days). Notably, Eliot's cross-ticker track record shows a 100.00% well-timed rate on prior sells, and his only prior trade at ATEC (a sale on 2024-06-12) also demonstrated well-timed selling, with a -48.8% 90-day return after the transaction. The company context is material: ATEC reported $196.5M in quarterly revenue with +26.8% annual growth, but the company remains unprofitable with $-28.6M net income over its most recent full fiscal year. The scale of this transaction and the insider's demonstrated track record of well-timed selling, combined with the company's ongoing losses despite revenue growth, warrant investor attention to whether this sale reflects confidence in near-term valuation levels or broader conviction shifts.

June 2024
high
Sell
50,232 shares
$546,524
Significance 6/10

General Counsel Marshall Eliot sells 50,232 shares of ATEC at $10.88; holdings reduced -17.0% vs pre-transaction baseline.

Marshall Eliot, the General Counsel & Corporate Secretary of Alphatec Holdings, sold 50,232 shares at $10.88 on 2024-06-12, reducing his holdings by 17.0% to 245,638 shares remaining. The transaction occurred at a stock price 43.3% below the 52-week high of $18.80 and amid a period of weakness, with the stock down 18.6% over 90 days prior to the sale. While Alphatec demonstrates strong revenue growth of 37.4% year-over-year, the company posted negative net income of $-48,495,000.00 in the latest quarter and remained unprofitable on a full-year basis, creating tension between top-line expansion and profitability. A material reduction in holdings by a C-suite executive during a period of stock weakness and ongoing losses merits investor attention to understand the operational context and cash position supporting continued growth investments.

Related insiders